Catheter-based sympathetic renal denervation (RDN) is a novel iteration of a historical but effective treatment for hypertension. A number of different device systems have demonstrated a ...
The Symplicity studies suggest that intravascular renal sympathetic nervous denervation improves blood pressure in patients with resistant hypertension, thus potentially opening a market for ...
A minimally invasive procedure used to treat resistant hypertension or high blood pressure that does not respond to other ...
Stop the Spread. Injecting saline into mouse kidneys did not affect the left or right substantia nigra (top). Injecting fibrils of α-synuclein ablated about half of the dopaminergic neurons (middle ...
Renal denervation works by changing how the sympathetic nervous system around the kidneys, or renal sympathetics, communicates with the brain, eliminating the feedback that says blood pressure needs ...
Against this backdrop, catheter-based renal denervation (RDN) has emerged as a novel interventional strategy for the management of treatment-resistant hypertension. RDN involves the selective ...
Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...
Healio wrote about this trial and interviewed the lead researcher. At the end of 2023, the FDA approved two renal denervation systems for the treatment of hypertension. “Anytime we have a new ...
Chronically instrumented rats were exposed to cold temperatures (10 °C) over 4 days after a control period (24 °C), and renal and lumbar sympathetic nerve activities were simultaneously measured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback